Status and phase
Conditions
Treatments
About
Botulinum toxin produced beneficial effects in spasticity in the hemiplegic upper limb. This study will test if botulinum toxin injections at earlier phases (<or = 3 months) in spasticity improve functional and motor tests compared with late injections (>or = 6 months).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Minimum age 18
Spastic hemiplegia after ischemic stroke (carotid occlusion) within the past 3 months.
Antispasticity medication stabilized for the last 30 days
Severe cognitive impairment such that patient is unable to provide scale assessment.
Significant spasticity impeding improvement by re-education for 2 months or less
Lack of muscular retraction defined by a minimal range of articular motion as :
Antagonist muscles (to spasticity) activity score 1 or more
Social Security benefits
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
Loading...
Central trial contact
Franck Durif
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal